Symbol Name ID |
Spink5
serine peptidase inhibitor, Kazal type 5 MGI:1919682 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
F2rl1tm1Cgh/F2rl1tm1Cgh Spink5tm1Hov/Spink5tm1Hov involves: 129P2/OlaHsd * 129S4/SvJae |
abnormal epidermis stratum corneum morphology | J:180855 |
abnormal skin morphology | J:180855 | |
abnormal vibrissa morphology | J:180855 | |
acanthosis | J:180855 | |
dehydration | J:180855 | |
neonatal lethality, complete penetrance | J:180855 | |
Klk6tm1Gsot/Klk6tm1Gsot Spink5tm1Drh/Spink5tm1Drh involves: 129P2/OlaHsd * C57BL/6 |
abnormal cytokine level | J:289877 |
abnormal epidermis stratum corneum morphology | J:289877 | |
abnormal skin morphology | J:289877 | |
abnormal vibrissa morphology | J:289877 | |
decreased inflammatory response | J:289877 | |
epidermal desquamation | J:289877 | |
impaired skin barrier function | J:289877 | |
normal integument phenotype | J:289877 | |
neonatal lethality, complete penetrance | J:289877 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
![]() |
|